Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

T Rowe Price Health Sciences Fd: (MF: PRHSX)

(MF) As of Nov 21, 2014 06:05 PM ET

 Add to portfolio

$74.12 USD

+0.35 (0.47%)

Zacks MF Rank : 2 - Buy [?]   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Oct 31, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Oct 31, 2014) 26.36
Objective Sector - Health
Peer HL MG

Zacks Premium Research for PRHSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Buy 2
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 39.64
Net Assets (Mil $) 10/31/2014 9,384.00
%Turnover 10/31/2014 54.80

Allocation

% of Portfolio
Large Growth 50.28
Large Value 0.00
Small Growth 8.01
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 17.45
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 10/31/2014 % of Portfolio
Health 47.49
Services 12.74
Finance 11.39
Retail Trade 8.95
Industrial Cyclical 7.43
Other 6.34
Technology 4.78
Non-Durable 0.88

Portfolio Holdings

Top Equity Holdings
(As of 6/30/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 4.92 461.25
ALEXION PHARMACEUTICALS I 4.72 442.47
MCKESSON CORP 3.44 322.68
BIOGEN IDEC INC 3.42 321.14
UNITEDHEALTH GROUP INC 3.37 316.00
AETNA INC 3.31 310.84
VALEANT PHARMACEUTICALS 3.13 294.16
ALLERGAN INC 2.93 274.61
AGILENT TECHNOLOGIES INC 2.69 252.30

Stock Holding % of Net Assets

As Of 6/30/2014
Total Issues 138
Avg. P/E 26.58
Avg. P/Book 5.07
Avg. EPS Growth 14.14
Avg. Market Value (Mil $) 37,725

Risk

3 Year 5 Year 10 Year
Beta 1.04 0.92 0.88
Alpha 14.49 13.03 9.78
R Squared 0.47 0.62 0.64
Std. Dev. 13.78 15.32 16.33
Sharpe 2.78 2.02 1.00